Medsider: Learn from Medtech and Healthtech Founders and CEOs

In this episode of Medsider Radio, we sat down with Alfred Griffin , co-founder and CEO of LightForce . LightForce is the developer of the world's first fully customized 3D-printed bracket system directly personalized for each patient's digital treatment plan. Alfred holds a DMD and PhD in Craniofacial Biology from the Medical University of South Carolina and completed his orthodontic residency at...

In this episode, we sat down with Laura Yecies ( https://www.linkedin.com/in/laurayecies/ ), CEO of Osteoboost ( https://www.osteoboost.com/ ). Osteoboost is the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women....

In this episode of Medsider Radio , we sat down with Laura Yecies , CEO of Osteoboost . Osteoboost is the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women. Laura brings over 30 years of experience across technology, digital health, and medical innovation, with a focus on overlooked gaps in women's health. She previously served as CEO of SugarSync (acquired...

In this episode, we sat down with Stephen Belcher ( https://www.linkedin.com/in/marketingmedicaldevices/ ), co-founder and CEO of Secure Closure ( https://www.secure-closure.com/ ). Secure Closure is developing Quattro-Close, a device designed for larg...

In this episode of Medsider Radio , we sat down with Stephen Belcher , co-founder and CEO of Secure Closure . Secure Closure is developing Quattro-Close, a device designed for large-bore femoral access sites. Trained as a veterinarian, Stephen has spent more than 25 years in the medical device industry, with deep experience in vascular access and closure technologies. He previously held commercial...

In this episode, we sat down with Daniel Estay ( https://www.linkedin.com/in/daniel-estay-22a07271/ ), founder and CEO of SonoVascular ( https://www.sonovascular.com/ ). SonoVascular has developed a novel mechanical-pharmaco ultrasound facilitated thro...

In this episode of Medsider Radio , we sat down with Daniel Estay , founder and CEO of SonoVascular . SonoVascular has developed a novel mechanical-pharmaco ultrasound facilitated thrombectomy system, SonoThrombectomy, that utilizes microbubble-mediated cavitation as a core enabling mechanism to remove blood clots more effectively. Dan has over 35 years of global medtech experience, including busi...

In this episode, we sat down with Matthias Hofmann ( https://www.linkedin.com/in/mchofmann/ ), CEO of Eyebot ( https://www.eyebot.co/ ). Eyebot is commercializing retail kiosks that deliver quick, efficient vision testing. Before Eyebot, Matthias led p...

In this episode of Medsider Radio , we sat down with Matthias Hofmann , CEO of Eyebot . Eyebot is commercializing retail kiosks that deliver quick, efficient vision testing. Before Eyebot, Matthias led product development at Formlabs and served as an R&D lead at EyeNetra, where he helped bring the first smartphone-based vision test to market. He holds a Ph. D. in Electrical Engineering with gr...

In this episode, we sat down with Massimiliano (Max) Colella ( https://www.linkedin.com/in/massimilianocolellajnj/ ), CEO of CMR Surgical ( https://cmrsurgical.com/ ). CMR Surgical is developing Versius, a surgical robot designed to make minimally inva...

In this episode of Medsider Radio , we sat down with Massimiliano (Max) Colella , CEO of CMR Surgical . CMR Surgical is developing Versius, a surgical robot designed to make minimally invasive procedures more accessible across specialties. Max brings more than three decades of healthcare leadership experience spanning medtech and hospital systems. He previously held leadership roles at Johnson &am...

In this episode, we sat down with Rick Bente ( https://www.linkedin.com/in/rick-bente/ ), co-founder and CEO of Indomo ( https://www.indomotx.com/ ). Indomo’s flagship device, ClearPen, is an investigational at-home corticosteroid injection designed to...

In this episode of Medsider Radio , we sat down with Rick Bente , co-founder and CEO of Indomo . Indomo’s flagship device, ClearPen, is an investigational at-home corticosteroid injection designed to treat inflammatory acne. Rick has over 20 years of experience as an engineer and operator across medtech and pharma, with leadership roles at Medtronic, Insulet, and YourBio, focused on drug delivery...

In this episode, we sat down with Shaun Bagai ( https://www.linkedin.com/in/shaun-r-bagai/ ), CEO of RenovoRx ( https://www.linkedin.com/company/renovorx/ ). The company is developing targeted oncology therapies and is currently commercializing RenovoC...

In this episode of Medsider Radio , we sat down with Shaun Bagai , CEO of RenovoRx .  The company is developing targeted oncology therapies and is currently commercializing RenovoCath, which is focused on pancreatic cancer.  Before joining RenovoRx in 2014, Shaun spent over a decade in the cardiovascular space, including leading global market development at HeartFlow and helping establish the Euro...

In this episode, we sat down with Justin Zenanko ( https://www.linkedin.com/in/justin-zenanko-83641864 ), co-founder & CEO of SynerFuse ( https://www.synerfuse.com/ ). SynerFuse is developing the e-TLIF procedure, which combines spinal fusion with neur...

In this episode of Medsider Radio , we sat down with Justin Zenanko , co-founder & CEO of SynerFuse . SynerFuse is developing the e-TLIF procedure, which combines spinal fusion with neuromodulation by placing leads directly at exposed nerves during surgery. A certified public accountant and serial entrepreneur, Justin previously served as CFO and senior vice president of corporate development...

In this episode, we sat down with Marina Pavlovic Rivas ( https://www.linkedin.com/in/marinapavlovicrivas/ ), co-founder & CEO of Eli Health ( https://eli.health/ ). The company is focused on making hormone data accessible in real time through its sali...

In this episode of Medsider Radio , we sat down with Marina Pavlovic Rivas , co-founder & CEO of Eli Health . The company is focused on making hormone data accessible in real time through its saliva-based testing system that delivers results through a mobile app.  A data scientist by training, Marina previously founded Gradiant AI, a machine learning company that was acquired in 2019.  In this...

In this episode, we sat down with Greg Walters ( https://www.linkedin.com/in/greg-walters-7b5a2917/ ), co-founder & CEO of Excision Medical ( https://www.excisionmed.com/ ). Excision is developing a leaflet modification system to enable lifetime manage...

In this episode of Medsider Radio , we sat down with Greg Walters , co-founder & CEO of Excision Medical . Excision is developing a leaflet modification system to enable lifetime management of aortic stenosis. Greg has almost 40 years of experience in cardiovascular devices, holding leadership roles at Kensey Nash Corporation where he led the development of Angio-Seal and several endovascular...

In this episode, we sat down with Jaeson Bang ( https://www.linkedin.com/in/jaeson-bang-1a29aa1a ), Founder & CEO of Future Cardia ( https://www.futurecardia.com/ ). Future Cardia is developing a subcutaneous heart-failure monitoring platform designed ...

In this episode of Medsider Radio , we sat down with Jaeson Bang , Founder & CEO of Future Cardia . Future Cardia is developing a subcutaneous heart-failure monitoring platform designed to capture both electrical and mechanical cardiac signals through a simple office-based procedure. Jaeson brings more than two decades of experience building implantable cardiac technologies across Medtronic, C...

In this episode, we sat down Dr. Adam Kadlec ( https://www.linkedin.com/in/adam-kadlec-195a67b2/ ), practicing urologist and co-founder of Rivermark Medical ( https://www.rivermarkmedical.com/ ). Rivermark is a clinical-stage company developing FloSten...

In this episode of Medsider Radio , we sat down Dr. Adam Kadlec , practicing urologist and co-founder of Rivermark Medical . Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH). Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experien...